|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228 TWD | +0.66% |
|
+2.70% | +11.76% |
Sunmax Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 393.09 million compared to TWD 324.77 million a year ago. Net income was TWD 128.17 million compared to TWD 132.96 million a year ago.
Basic earnings per share from continuing operations was TWD 2.35 compared to TWD 2.44 a year ago. Diluted earnings per share from continuing operations was TWD 2.35 compared to TWD 2.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.76% | 381M | |
| +0.17% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +5.23% | 24.63B | |
| -24.79% | 18.2B | |
| +26.69% | 12.01B | |
| -3.13% | 11.76B | |
| +6.57% | 10.4B | |
| -18.08% | 9.94B |
SUNMAX BIOTECHNOLOGY CO., LTD. 
